Crossref journal-article
Elsevier BV
Cancer Cell (78)
Bibliography

Weisberg, E., Boulton, C., Kelly, L. M., Manley, P., Fabbro, D., Meyer, T., Gilliland, D. G., & Griffin, J. D. (2002). Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412. Cancer Cell, 1(5), 433–443.

Authors 8
  1. Ellen Weisberg (first)
  2. Christina Boulton (additional)
  3. Louise M Kelly (additional)
  4. Paul Manley (additional)
  5. Doriano Fabbro (additional)
  6. Thomas Meyer (additional)
  7. D.Gary Gilliland (additional)
  8. James D Griffin (additional)
References 36 Referenced 506
  1. {'key': '10.1016/S1535-6108(02)00069-7_BIB1', 'first-page': '118a', 'article-title': 'FLT3-targeted tyrosine kinase inhibitors inhibit proliferation, induce apoptosis, and improve survival in a murine leukemia model utilizing FLT3/ITD-transformed cells', 'volume': '98', 'author': 'Allebach', 'year': '2001', 'journal-title': 'Blood'} / Blood / FLT3-targeted tyrosine kinase inhibitors inhibit proliferation, induce apoptosis, and improve survival in a murine leukemia model utilizing FLT3/ITD-transformed cells by Allebach (2001)
  2. 10.1038/nm0797-730 / Nat. Med. / Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell by Bonnet (1997)
  3. 10.1073/pnas.85.23.9312 / Proc. Natl. Acad. Sci. USA / Transformation of an interleukin-3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific p210 BCR/ABL protein by Daley (1988)
  4. {'key': '10.1016/S1535-6108(02)00069-7_BIB4', 'first-page': '261', 'article-title': 'Effects of FLT3 ligand on human leukemia cells. I. Proliferative response of myeloid leukemia cells', 'volume': '10', 'author': 'Dehmel', 'year': '1996', 'journal-title': 'Leukemia'} / Leukemia / Effects of FLT3 ligand on human leukemia cells. I. Proliferative response of myeloid leukemia cells by Dehmel (1996)
  5. {'key': '10.1016/S1535-6108(02)00069-7_BIB5', 'first-page': '17', 'article-title': 'PKC412–a protein kinase inhibitor with a broad therapeutic potential', 'volume': '15', 'author': 'Fabbro', 'year': '2000', 'journal-title': 'Anticancer Drug Des.'} / Anticancer Drug Des. / PKC412–a protein kinase inhibitor with a broad therapeutic potential by Fabbro (2000)
  6. 10.1046/j.1365-2141.2000.01831.x / Br. J. Haematol. / Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cells by Fenski (2000)
  7. 10.1038/sj.onc.1203354 / Oncogene / Tandem-duplicated FLT3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines by Hayakawa (2000)
  8. 10.1016/S0168-1656(00)00399-0 / J. Biotech. / Expression and purification of human recombinant GST-FGF Receptor-1 by Homann (2001)
  9. 10.1038/sj.leu.2400770 / Leukemia / Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia by Horiike (1997)
  10. 10.1038/sj.leu.2401241 / Japan. Leukemia. / Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia. The Children's Cancer and Leukemia Study Group by Iwai (1999)
  11. 10.1182/blood.V99.1.310 / Blood / FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model by Kelly (2002)
  12. 10.1038/sj.leu.2400756 / Leukemia / Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho) by Kiyoi (1997)
  13. 10.1038/sj.leu.2401130 / Leukemia / Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product by Kiyoi (1998)
  14. {'key': '10.1016/S1535-6108(02)00069-7_BIB14', 'first-page': '3074', 'article-title': 'Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia', 'volume': '93', 'author': 'Kiyoi', 'year': '1999', 'journal-title': 'Blood'} / Blood / Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia by Kiyoi (1999)
  15. 10.1002/(SICI)1096-911X(199912)33:6<525::AID-MPO1>3.0.CO;2-8 / Med. Pediatr. Oncol. / Prognostic value of internal tandem duplication of the FLT3 gene in childhood acute myelogenous leukemia by Kondo (1999)
  16. 10.1182/blood.V98.3.885 / Blood / A FLT3 tyrosine kinase inhibitor is selectively cytotoxic to acute myeloid leukemia blasts harboring FLT3 internal tandem duplication mutations by Levis (2001)
  17. {'key': '10.1016/S1535-6108(02)00069-7_BIB17', 'first-page': '721a', 'article-title': 'FLT3-targeted inhibitors kill FLT3-dependent modeled cells, leukemia-derived cells lines, and primary AML blasts in vitro and in vivo', 'volume': '98', 'author': 'Levis', 'year': '2001', 'journal-title': 'Blood'} / Blood / FLT3-targeted inhibitors kill FLT3-dependent modeled cells, leukemia-derived cells lines, and primary AML blasts in vitro and in vivo by Levis (2001)
  18. 10.1093/emboj/19.8.1827 / EMBO J. / Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia by Liu (2000)
  19. {'key': '10.1016/S1535-6108(02)00069-7_BIB19', 'first-page': '118a', 'article-title': 'Selective apoptosis of mutant FLT3-transformed leukemia cells by Hsp90-inhibitors', 'volume': '98', 'author': 'Minami', 'year': '2001', 'journal-title': 'Blood'} / Blood / Selective apoptosis of mutant FLT3-transformed leukemia cells by Hsp90-inhibitors by Minami (2001)
  20. {'key': '10.1016/S1535-6108(02)00069-7_BIB20', 'first-page': '1911', 'article-title': 'Internal tandem duplication of the FLT3 gene found in acute myeloid leukemia', 'volume': '10', 'author': 'Nakao', 'year': '1996', 'journal-title': 'Leukemia'} / Leukemia / Internal tandem duplication of the FLT3 gene found in acute myeloid leukemia by Nakao (1996)
  21. {'key': '10.1016/S1535-6108(02)00069-7_BIB21', 'first-page': '118a', 'article-title': 'SUGEN compounds SU5416 and SU11248 inhibit FLT3 activity', 'volume': '98', 'author': "O'Farrell", 'year': '2001', 'journal-title': 'Blood'} / Blood / SUGEN compounds SU5416 and SU11248 inhibit FLT3 activity by O'Farrell (2001)
  22. {'key': '10.1016/S1535-6108(02)00069-7_BIB22', 'first-page': '1147', 'article-title': 'p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines', 'volume': '13', 'author': 'Okuda', 'year': '1996', 'journal-title': 'Oncogene'} / Oncogene / p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines by Okuda (1996)
  23. 10.1111/j.1600-0609.1996.tb00483.x / Eur. J. Haematol. / Cell differentiation in acute myeloid leukemia by Olsson (1996)
  24. 10.1038/86515 / Nat. Med. / AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia by Pabst (2001)
  25. 10.1200/JCO.2001.19.5.1485 / J. Clin. Oncol. / Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C by Propper (2001)
  26. 10.1038/sj.leu.2401731 / Leukemia / Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the FLT3 gene by Rombouts (2000)
  27. {'key': '10.1016/S1535-6108(02)00069-7_BIB27', 'first-page': '595', 'article-title': 'Hematopoietic receptors of Class III Receptor-Type tyrosine kinases', 'volume': '4', 'author': 'Rosnet', 'year': '1993', 'journal-title': 'Crit. Rev. Oncog.'} / Crit. Rev. Oncog. / Hematopoietic receptors of Class III Receptor-Type tyrosine kinases by Rosnet (1993)
  28. {'key': '10.1016/S1535-6108(02)00069-7_BIB28', 'first-page': '839', 'article-title': 'The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3′ kinase pathway', 'volume': '12', 'author': 'Sattler', 'year': '1996', 'journal-title': 'Oncogene'} / Oncogene / The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3′ kinase pathway by Sattler (1996)
  29. 10.1093/emboj/17.18.5321 / EMBO J. / Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes by Schwaller (1998)
  30. {'key': '10.1016/S1535-6108(02)00069-7_BIB30', 'first-page': '299', 'article-title': 'An acute myeloid leukemia gene, AML1, regulates transcriptional activation and hemopoietic myeloid cell differentiation antagonistically by two alternative spliced forms', 'volume': '1111', 'author': 'Tanaka', 'year': '1997', 'journal-title': 'Leukemia'} / Leukemia / An acute myeloid leukemia gene, AML1, regulates transcriptional activation and hemopoietic myeloid cell differentiation antagonistically by two alternative spliced forms by Tanaka (1997)
  31. 10.1038/sj.leu.2402199 / Leukemia / Inhibition of FLT3-mediated transformation by use of a tyrosine kinase inhibitor by Tse (2001)
  32. 10.1182/blood.V95.11.3498 / Blood / Mechanism of resistance to the ABL tyrosine kinase inhibitor STI571 in BCR/ABL-transformed hematopoietic cell lines by Weisberg (2000)
  33. 10.1111/j.1365-2141.1999.01284.x / Br. J. Haematol. / Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children by Xu (1999)
  34. 10.1182/blood.V97.8.2434 / Blood / Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies by Yamamoto (2001)
  35. {'key': '10.1016/S1535-6108(02)00069-7_BIB35', 'first-page': '838a', 'article-title': 'SU5416 and SU5614 inhibit wild-type and activated mutant FLT3 signaling in leukemia cells', 'volume': '98', 'author': 'Yee', 'year': '2001', 'journal-title': 'Blood'} / Blood / SU5416 and SU5614 inhibit wild-type and activated mutant FLT3 signaling in leukemia cells by Yee (2001)
  36. 10.1038/sj.leu.2401680 / Leukemia / In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor by Zhao (2000)
Dates
Type When
Created 22 years, 10 months ago (Oct. 11, 2002, 1:33 p.m.)
Deposited 5 years, 6 months ago (March 5, 2020, 11:07 a.m.)
Indexed 1 week ago (Aug. 30, 2025, 1:07 p.m.)
Issued 23 years, 3 months ago (June 1, 2002)
Published 23 years, 3 months ago (June 1, 2002)
Published Print 23 years, 3 months ago (June 1, 2002)
Funders 0

None

@article{Weisberg_2002, title={Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412}, volume={1}, ISSN={1535-6108}, url={http://dx.doi.org/10.1016/s1535-6108(02)00069-7}, DOI={10.1016/s1535-6108(02)00069-7}, number={5}, journal={Cancer Cell}, publisher={Elsevier BV}, author={Weisberg, Ellen and Boulton, Christina and Kelly, Louise M and Manley, Paul and Fabbro, Doriano and Meyer, Thomas and Gilliland, D.Gary and Griffin, James D}, year={2002}, month=jun, pages={433–443} }